agilon health, inc. (NYSE:AGL) Shares Sold by Capital World Investors

Capital World Investors cut its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 4.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 46,308,236 shares of the company's stock after selling 2,059,773 shares during the period. Capital World Investors owned 11.24% of agilon health worth $87,986,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Oak Thistle LLC bought a new stake in shares of agilon health in the 4th quarter valued at about $25,000. Ieq Capital LLC purchased a new position in shares of agilon health in the fourth quarter worth $26,000. Signaturefd LLC grew its holdings in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of agilon health in the fourth quarter valued at about $33,000. Finally, Cerity Partners LLC purchased a new position in shares of agilon health in the fourth quarter worth about $34,000.

agilon health Price Performance

AGL stock traded up $0.07 during trading on Friday, hitting $3.89. The stock had a trading volume of 3,612,723 shares, compared to its average volume of 4,822,564. The company's 50-day moving average price is $4.18 and its two-hundred day moving average price is $3.14. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The stock has a market capitalization of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Analyst Ratings Changes

AGL has been the topic of a number of research reports. Stifel Nicolaus increased their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. TD Cowen increased their price target on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Citigroup raised agilon health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $3.25 to $5.00 in a report on Friday. Robert W. Baird dropped their target price on agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Finally, Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $3.30 to $8.50 in a research report on Tuesday, April 8th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $4.81.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.